Patents by Inventor Akihisa Takamizawa

Akihisa Takamizawa has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6217872
    Abstract: Disclosed is an isolated non-A, non-B hepatitis virus genomic CDNA covering the entire region of the virus gene nucleotide sequence from the 1st to 9416th nucleotides shown in FIG. 2(1) through FIG. 2(16) hereof, wherein the coding region is from the 333rd to 9362nd nucleotides, and the 5′- and 3′-noncoding sequences contain 332 nucleotides and 54 nucleotides, respectively. Part of the cDNA and an antigen polypeptide as an expression product thereof are useful as a diagnostic reagent for non-A, non-B hepatitis. The antigen polypeptide is also useful as an active ingredient for a non-A, non-B hepatitis virus vaccine.
    Type: Grant
    Filed: May 21, 1999
    Date of Patent: April 17, 2001
    Assignee: The Research Foundation for Microbial Diseases of Osaka University
    Inventors: Hiroto Okayama, Isao Fuke, Chisato Mori, Akihisa Takamizawa, Iwao Yoshida
  • Patent number: 5998130
    Abstract: Disclosed is an isolated non-A, non-B hepatitis virus genomic cDNA covering the entire region of the virus gene nucleotide sequence from the 1st to 9416th nucleotides shown in FIG. 2(1) through FIG. 2(16) hereof, wherein the coding region is from the 333rd to 9362nd nucleotides, and the 5'- and 3'- noncoding sequences contain 332 nucleotides and 54 nucleotides, respectively. Part of the cDNA and an antigen polypeptide as an expression product thereof are useful as a diagnostic reagent for non-A, non-B hepatitis. The antigen polypeptide is also useful as an active ingredient for a non-A, non-B hepatitis virus vaccine.
    Type: Grant
    Filed: August 1, 1997
    Date of Patent: December 7, 1999
    Assignee: The Research Foundation for Microbial Diseases of Osaka University
    Inventors: Hiroto Okayama, Isao Fuke, Chisato Mori, Akihisa Takamizawa, Iwao Yoshida
  • Patent number: 5847101
    Abstract: Disclosed is an isolated non-A, non-B hepatitis virus genomic cDNA covering the entire region of the virus gene nucleotide sequence from the 1st to 9416th nucleotides shown in FIG. 2(1) through FIG. 2(16) hereof, wherein the coding region is from the 333rd to 9362nd nucleotides, and the 5'- and 3'-noncoding sequences contain 332 nucleotides and 54 nucleotides, respectively. Part of the cDNA and an antigen polypeptide as an expression product thereof are useful as a diagnostic reagent for non-A, non-B hepatitis. The antigen polypeptide is also useful as an active ingredient for a non-A, non-B hepatitis virus vaccine.
    Type: Grant
    Filed: February 6, 1995
    Date of Patent: December 8, 1998
    Assignee: The Research Foundation for Microbial Diseases of Osaka University
    Inventors: Hiroto Okayama, Isao Fuke, Chisato Mori, Akihisa Takamizawa, Iwao Yoshida
  • Patent number: 5747339
    Abstract: Disclosed is an isolated non-A, non-B hepatitis virus genomic cDNA covering the entire region of the virus gene nucleotide sequence from the 1st to 9416th nucleotides shown in FIG. 2(1) through FIG. 2(16) hereof, wherein the coding region is from the 333rd to 9362nd nucleotides, and the 5'- and 3'-noncoding sequences contain 332 nucleotides and 54 nucleotides, respectively. Part of the cDNA and an antigen polypeptide as an expression product thereof are useful as a diagnostic reagent for non-A, non-B hepatitis. The antigen polypeptide is also useful as an active ingredient for a non-A, non-B hepatitis virus vaccine.
    Type: Grant
    Filed: October 18, 1994
    Date of Patent: May 5, 1998
    Assignee: Research Foundation for Microbial Diseases of Osaka
    Inventors: Hiroto Okayama, Isao Fuke, Chisato Mori, Akihisa Takamizawa, Iwao Yoshida
  • Patent number: 5693497
    Abstract: There is disclosed an antigen comprising an amino acid sequence of the suce antigen of a hepatitis B virus. The present antigen can be produced easily and safely at low cost by means of recombinant DNA technique. The present antigen can be used as an effective vaccine and diagnostic for hepatitis B.
    Type: Grant
    Filed: January 25, 1995
    Date of Patent: December 2, 1997
    Assignee: The Research Foundation for Microbial Diseases of Osaka University
    Inventors: Akihisa Takamizawa, Hiroyuki Fujita, Sadao Manabe, Masahiko Kato, Juichiro Osame, Iwao Yoshida, Takeo Konobe, Keisuke Takaku
  • Patent number: 5650153
    Abstract: There is provided a recombinant Marek's disease virus comprising the genomic DNA of an attenuated Marek's disease virus and a foreign gene from another source. The present recombinant virus can advantageously be used as an active ingredient for a multifunctional live vaccine, exhibiting not only the antigenicity and immunogenicity of the Marek's disease virus but also the properties ascribed to the foreign gene. Since the suitable host cell for the recombinant virus of the present invention is an avian cell which is available in a large quantity and not expensive, the recombinant virus of the present invention can be produced efficiently at low cost on a commercial scale.
    Type: Grant
    Filed: August 24, 1994
    Date of Patent: July 22, 1997
    Assignee: The Research Foundation for Microbial Diseases
    Inventors: Toyokazu Ishikawa, Sadao Manabe, Chisato Mori, Akihisa Takamizawa, Iwao Yoshida, Juichiro Osame, Keisuke Takaku, Konosuke Fukai
  • Patent number: 4902783
    Abstract: There is disclosed a method for purifying a gene-expression product produced by recombinant DNA technique which comprises a specific sequence of steps including adsorption treatment with silica gel, adsorption treatment with activated carbon, at least twice density gradient centrifugation and at least twice equilibrium density gradient centrifugation. The method of the present invention is very effective to remove allergen from gene-expression products contaminated therewith, enabling highly purified gene-expression products to be produced on a large scale.
    Type: Grant
    Filed: June 15, 1987
    Date of Patent: February 20, 1990
    Assignee: The Research Foundation for Microbial Diseases of Osaka University
    Inventors: Hideo Goda, Toshiyuki Akiyama, Akihisa Takamizawa, Iwao Yoshida, Takeo Konobe, Keisuke Takaku